Background: Stenotrophomonas maltophilia is an opportunistic human pathogen causing nosocomial infections worldwide. S. maltophilia infection is of particular concern due to its inherent resistance to currently used antibiotics. Proton motive force-driven transporters of the major facilitator superfamily frequently contribute to the efflux of substances, including antibiotics, across cell membranes.
Introduction
Stenotrophomonas maltophilia is a ubiquitous Gram-negative soil bacterium that has become an important pathogen causing hospital-acquired infections associated with high mortality rates. S. maltophilia is endowed with multiple inherent mechanisms required for MDR, such as antibiotic degradation enzymes, different drug modifying enzymes and several multidrug efflux pumps. 1 Antibiotics in the fluoroquinolone class are often used for treating S. maltophilia infections. However, S. maltophilia contains two known chromosomally encoded determinants that are associated with intrinsic resistance to fluoroquinolone antibiotics, namely the tripartite drug efflux pump SmeDEF 2 and SmQnr, 3 a protein homologous to Qnr, which is capable of binding to the quinolone drug targets, DNA gyrase and topoisomerases, 4, 5 thereby protecting bacterial cells from fluoroquinolones. Recently, S. maltophilia MfsA, a membrane efflux pump belonging to the major facilitator superfamily (MFS), has been characterized. 6 MFS proteins are active membrane transporters that facilitate the efflux of a diverse range of substances including toxins and xenobiotics. 7 Deletion of mfsA in S. maltophilia confers decreased resistance to paraquat and other structurally unrelated antibiotics including fluoroquinolones. 8 The expression of mfsA is directly controlled by SoxR, a member of the MerR family of transcriptional regulators. 6 SoxR commonly senses elevated levels of intracellular superoxide anion through oxidation of its two iron/two sulphur cluster. This causes a conformational change to a form that facilitates binding of RNA polymerase to the target gene promoter, resulting in increased gene expression. Under physiological conditions, S. maltophilia SoxR represses mfsA expression. Upon exposure to superoxide generators, SoxR is oxidized and becomes a transcriptional activator of mfsA expression. 6 During the infection processes, S. maltophilia confronts superoxide anions generated as a part of the host innate immune response inside the phagolysosome. It would therefore be expected that the increased levels of superoxide anion would elicit high expression of mfsA. To mimic the increased expression of mfsA during superoxide stress, an mfsA overexpression strain was constructed. We show here that overexpression of mfsA encoded on a plasmid vector resulted in increased resistance to fluoroquinolones, thus supporting the idea that exposure to host-generated superoxide stress during hostmicrobe interaction would lead to increased resistance to fluoroquinolone antibiotics in S. maltophilia.
Materials and methods
Bacterial strains and growth conditions S. maltophilia K279a and mutant strains were cultured aerobically in LB medium (Difco, USA) at 37 C with continuous shaking (150 rpm). Exponential-phase cells were used in all experiments.
Construction of pMfsA and pMfsA(Tp) plasmid
The S. maltophilia mfsA expression plasmid, pMfsA, was constructed by PCR amplifying the full-length mfsA gene from S. maltophilia K279a genomic DNA using BT5012-(5 0 -TCTGACCCGTATGACCCCGA-3 0 ) and BT2835-(5 0 -GCGGCGCTACACCCGTCG-3 0 ) primers. The blunt end 1388 bp PCR product was cloned into the broad-host-range expression vectors, pBBR1MCS- 5 9 and pBBR1-Tp, at the SmaI site, generating pMfsA and pMfsA(Tp), respectively. The expression of mfsA was driven from the lac promoter of the vector. pBBR1-Tp was constructed by cloning of a KpnI (blunt ended) fragment containing dfr, which encodes dihydrofolate reductase (trimethoprim resistance, Tp r ), from pGSTp 10 into pBBR1MCS-1 9 digested with AatII (blunt ended) and NcoI (blunt ended) to remove the chloramphenicol acetyltransferase gene.
Disc diffusion assay
Antibiotic susceptibility of S. maltophilia strains was determined using the standard Kirby-Bauer disc diffusion method. 11 The following antibiotic discs (Oxoid, UK) were used: nalidixic acid (30 lg), ciprofloxacin (5 lg), norfloxacin (5 lg), ofloxacin (5 lg), moxifloxacin (5 lg) and levofloxacin (5 lg). The paraquat discs were prepared by soaking the paper discs (diameter 5 mm) with 5 lL of 250 mM paraquat. The diameters of the zones of inhibition were measured after 18 h of incubation at 35 C.
Determination of MICs
MICs of antibiotics for S. maltophilia strains were determined using a standard broth dilution method.
11
Ciprofloxacin killing assay
The assay was modified from the colistin time-kill assay. 12 Logarithmic phase cultures of K279a WT and MfsA overexpression (K279a harbouring pMfsA) strains were adjusted to OD 600 of 0.1. Cell suspensions were challenged with 100 lM carbonyl cyanide m-chlorophenylhydrazone (CCCP) for 5 min before being treated with increasing concentrations of ciprofloxacin (0-400 mg/L) for 30 min. After treatment, cells were washed once with phosphate buffer (50 mM, pH 7.0) and the surviving cells were enumerated by viable plate count.
Results and discussion
We have shown previously that deletion of mfsA renders S. maltophilia more susceptible to multiple antibiotics relative to the isogenic WT strain. 8 The expression of mfsA is increased in response to exposure to redox cycling drugs/superoxide generators. 6 This mfsA induction is mediated by the superoxide sensor and transcriptional regulator, SoxR. Superoxide anion is one of the key components of the host innate immune response and is produced inside the phagolysosome to kill the invading microbes. To mimic conditions in which mfsA is highly expressed in response to exposure to host-generated superoxide stress, a full-length mfsA gene was cloned into a broad-host-range plasmid pBBR1MCS-5, generating pMfsA where mfsA was expressed via the lac promoter of the vector. S. maltophilia K279a containing pMfsA showed a marked increase (.16-fold) in the resistance levels to the redox cycling drug paraquat relative to S. maltophilia K279a WT. This phenotype is consistent with a previous suggestion in that MfsA is a paraquat efflux pump in S. maltophilia. 6 Interestingly, among the various classes of antibiotic tested, we found that high expression of mfsA rendered the strain more resistant to the fluoroquinolone drugs (Table 1) : ciprofloxacin (16-fold), norfloxacin (16-fold), ofloxacin (8-fold) and levofloxacin (8-fold). These antibiotics belong to the second generation of fluoroquinolones. 13 No alteration in the resistance level was observed for nalidixic acid and moxifloxacin, which are categorized as first-and fourthgeneration fluoroquinolones, respectively. This class of fluoroquinolones has a piperazine moiety side chain at position C7 of the core quinolone nucleus.
14 There is no structural relationship between paraquat and fluoroquinolones ( Figure S1 , available as Supplementary data at JAC Online). Moreover, the overexpression Vattanaviboon et al.
of a gene encoding efflux pump has been associated with clinically relevant MDR in several pathogenic bacteria. 15, 16 Transport through MFS efflux pumps is generally driven by the proton motive force and the proton motive force inhibitor, CCCP has been shown to inhibit MFS function. 17 If CCCP can inhibit MfsA's function as a fluoroquinolone efflux transporter, we would expect that pretreatment with CCCP should lessen the ciprofloxacin resistance level. We used the MfsA-overexpression strain (K279a harbouring pMfsA), which is highly resistant to ciprofloxacin as a test model. After treatment with 100 mg/L ciprofloxacin for 30 min, the MfsA-overexpression strain showed 45.9+11.2% survival. When bacterial cultures were pretreated with 100 lM CCCP for 5 min prior to ciprofloxacin treatment, the percentage survival was significantly reduced to 4.9+2.2% (P , 0.05, paired t-test), which was comparable to the survival level of K279a without CCCP pretreatment (2.2+0.9%) (data not shown). This result suggests that proton motive force is required for ciprofloxacin efflux mediated by MfsA and that inhibition of MfsA function in the overexpressed strain increased ciprofloxacin susceptibility.
To test whether heterologous expression of S. maltophilia mfsA in other soil and pathogenic bacteria conferred fluoroquinolone resistance, mfsA expression plasmids [pMfsA for Gm s bacteria and pMfsA(Tp) for Tp s bacteria] were introduced into various bacteria representing several phyla including Alphaproteobacteria (Agrobacterium tumefaciens), Betaproteobacteria (Burkholderia thailandensis) and Gammaproteobacteria (Pseudomonas aeruginosa MfsA confers fluoroquinolone resistance in S. maltophilia JAC and Escherichia coli) (Figure 1 ). None of these bacteria possesses coding DNA sequences orthologous to mfsA. The antibiotic susceptibility levels of these strains was determined using the disc diffusion method. 11 As illustrated in Figure 1 , A. tumefaciens NTL4, B. thailandensis, P. aeruginosa PA14 and E. coli K12 expressing mfsA were more resistant to the second-generation fluoroquinolones: ciprofloxacin, norfloxacin, ofloxacin and to a lesser extent levofloxacin. Moreover, heterologous expression of mfsA greatly increased paraquat resistance in all bacteria tested (Figure 1) . The result indicates the versatility of MfsA in that it can function as a fluoroquinolone drug efflux pump in a variety of genera of Gram-negative bacteria. This observation raises the intriguing possibility that horizontal gene transfer of mfsA would consequently lead to resistance to fluoroquinolones in other bacteria. However, based on surveys of current bacterial genome databases, 18 orthologues of MfsA have been identified only in members of the family Xanthomonadaceae and the order Actinomycetales (data not shown).
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